AZD0585 Phase III Long-term Study in Japan

Trial Identifier: D5884C00002
Sponsor: AstraZeneca
NCTID:: NCT02463071
Start Date: June 2015
Primary Completion Date: March 2017
Study Completion Date: March 2017
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Japan Aki-gun, Japan, 735-0021
Japan Chiba-shi, Japan, 261-0004
Japan Chofu-shi, Japan, 182-0006
Japan Fukuoka-shi, Japan, 812-0027
Japan Fukuoka-shi, Japan, 819-8551
Japan Fukuyama-shi, Japan, 721-0927
Japan Funabashi-shi, Japan, 273-0046
Japan Gifu-shi, Japan, 500-8717
Japan Itami-shi, Japan, 664-0846
Japan Kanazawa-shi, Japan, 921-8035
Japan Kawasaki-shi, Japan, 216-0006
Japan Koga-shi, Japan, 306-0232
Japan Komatsu-shi, Japan, 923-0861
Japan Nagoya-shi, Japan, 457-0046
Japan Naha-shi, Japan, 900-0032
Japan Niigata-shi, Japan, 950-1104
Japan Ota-ku, Japan, 144-0034
Japan Sendai-shi, Japan, 983-0835
Japan Sendai-shi, Japan, 981-0923
Japan Sendai-shi, Japan, 983-0039
Japan Shinagawa-ku, Japan, 141-6003
Japan Shinjuku-ku, Japan, 160-0017
Japan Takamatsu-shi, Japan, 760-0018
Japan Takamatsu-shi, Japan, 760-0076
Japan Toyonaka-shi, Japan, 560-0082
Japan Urasoe-shi, Japan, 901-2132